Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Australia Identifies HTA Challenges Posed By Emerging Technologies
Feb 16 2024
•
By
Ian Schofield
Cost will be a key factor in assessing whether new technologies should be subsidized • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Market Access